Shopping Cart
Remove All
Your shopping cart is currently empty
BETd-246 is an inhibitor of second-generation and PROTAC-based BET bromodomain (BRD), show antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $539 | Inquiry | Inquiry | |
| 10 mg | $789 | Inquiry | Inquiry | |
| 25 mg | $1,610 | Inquiry | Inquiry | |
| 50 mg | $2,440 | Inquiry | Inquiry | |
| 100 mg | Inquiry | Inquiry | Inquiry | |
| 200 mg | Inquiry | Inquiry | Inquiry |
| Description | BETd-246 is an inhibitor of second-generation and PROTAC-based BET bromodomain (BRD), show antitumor activity. |
| In vitro | BETd-246 treatment (0-100 nM, 1-3 h) leads to a dose-dependent reduction of BRD2, BRD3, and BRD4 in TNBC cell lines, with optimal effects observed at 30-100 nM for 1 hour or 10-30 nM for 3 hours. BETd-246 (100 nM, 24/48 hours) significantly inhibits growth and induces apoptosis in MDA-MB-468 cell lines. Additionally, BETd-246 (100 nM, 24 hours) causes marked cell cycle arrest and apoptosis in TNBC cell lines[1]. It induces rapid, time-dependent downregulation of MCL1 protein in all evaluated TNBC cell lines and exhibits stronger apoptosis induction than BETi-211. |
| In vivo | BETd-246 (5 mg/kg, IV, 3 times per week for 3 weeks) effectively inhibits WHIM24 tumor growth, similar to the antitumor activity of BETi-211 at a higher dose with more frequent administration. BETd-246 exhibits limited drug exposure in xenograft tumor tissue in MDA-M-231 and MDA-MB-468 models[1]. A dose of 10 mg/kg induces partial tumor regression during treatment without apparent toxicity. |
| Molecular Weight | 946.02 |
| Formula | C48H55N11O10 |
| Cas No. | 2140289-17-2 |
| Relative Density. | 1.51 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (211.41 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Corn Oil: 5 mg/mL (5.29 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.